Otonomy, Inc. Sustainability Profile
Otonomy, Inc., a leading biopharmaceutical company based in the United States, focuses on innovative therapies for ear diseases. Founded in 2011, Otonomy has made significant strides in the industry, particularly in the development of treatments for hearing loss and tinnitus. The company’s headquarters is located in San Diego, California, with operations extending across major regions in the US. Otonomy's core products, including OTO-313 and OTO-413, are designed to address unmet medical needs in otology, setting them apart with their unique delivery mechanisms and targeted action. With a commitment to advancing ear health, Otonomy has established a strong market position, recognised for its pioneering research and development efforts. The company continues to push the boundaries of what is possible in the field of ear therapeutics, aiming to improve the quality of life for patients worldwide.
DitchCarbon Score
How does Otonomy, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Otonomy, Inc.'s score of 23 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Otonomy, Inc.'s reported carbon emissions
Otonomy, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that Otonomy, Inc. may not yet have established a formal framework for addressing its carbon footprint or climate impact. As the industry increasingly prioritises sustainability, Otonomy's future initiatives in this area will be crucial for aligning with broader environmental goals.
How Carbon Intensive is Otonomy, Inc.'s Industry?
How Carbon Intensive is Otonomy, Inc.'s Location?
Otonomy, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Otonomy, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
